| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 50,163 | 49,783 |
| Net change in cash, cash equivalents and restricted cash | 51,989 | 58,348 |
| Cash and cash equivalents at beginning of period | 4,742 | - |
| Cash and cash equivalents at end of period | 56,731 | - |
Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA)